Interpretation of Evidence and research gaps identified during development of policy guidelines for tuberculosis (Second edition): tuberculosis related comorbidity

doi:10.19982/j.issn.1000-6621.20240076

Abstract

Abstract:

Addressing comorbidities and associated risk factors in patients with tuberculosis is crucial for eradicating the disease. In 2023, the World Health Organization released the second edition of Evidence and research gaps identified during development of policy guidelines for tuberculosis, which highlights the principal research gaps in tuberculosis-related comorbidities, notably in Mycobacterium tuberculosis/HIV co-infection, nutritional support and care, and among populations of injecting drug users. In this article, the author interprets these identified research gaps and summarizes China’s current research advancements in these areas, providing insights for professionals engaged in related fields.

Key words: Tuberculosis, Comorbidity, Summary report (topic)

CLC Number:

Liu Guizhen, Deng Guofang. Interpretation of Evidence and research gaps identified during development of policy guidelines for tuberculosis (Second edition): tuberculosis related comorbidity[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 618-624. doi: 10.19982/j.issn.1000-6621.20240076

References 36

[1]	World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
[2]	Bagcchi S. WHO’s Global Tuberculosis Report 2022. Lancet Microbe, 2023, 4(1): e20. doi:10.1016/S2666-5247(22)00359-7.
[3]	World Health Organization. Evidence and research gaps identified during development of policy guidelines for tuberculosis.2nd ed. Geneva: World Health Organization, 2023.
[4]	Fennelly KP, Martinez L, Mandalakas AM. Tuberculosis: First in Flight. Am J Respir Crit Care Med, 2022, 205(3): 272-274. doi:10.1164/rccm.202111-2513ED.
[5]	World Health Organization. Global Tuberculosis Report 2021. Geneva: World Health Organization, 2021.
[6]	Ford N, Matteelli A, Shubber Z, et al. TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis. J Int AIDS Soc, 2016, 19(1): 20714. doi:10.7448/IAS.19.1.20714. pmid: 26765347
[7]	Gupta RK, Lucas SB, Fielding KL, et al. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS, 2015, 29(15): 1987-2002. doi:10.1097/QAD.0000000000000802. pmid: 26266773
[8]	Montes K, Atluri H, Silvestre Tuch H, et al. Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting. J Clin Tuberc Other Mycobact Dis, 2021, 25: 100287. doi:10.1016/j.jctube.2021.100287.
[9]	Lönnroth K, Raviglione M. The WHO’s new End TB Strategy in the post-2015 era of the Sustainable Development Goals. Trans R Soc Trop Med Hyg, 2016, 110(3): 148-150. doi:10.1093/trstmh/trv108.
[10]	Sinha P, Davis J, Saag L, et al. Undernutrition and Tuberculosis: Public Health Implications. J Infect Dis, 2019, 219(9): 1356-1363. doi:10.1093/infdis/jiy675. pmid: 30476125
[11]	Ma JJ, Guo YJ, Li Z, et al. Prevalence and prognostic significance of malnutrition risk in patients with pulmonary tuberculosis: A hospital-based cohort study. Front Public Health, 2022, 10: 1039661. doi:10.3389/fpubh.2022.1039661.
[12]	Meijerink H, Wisaksana R, Lestari M, et al. Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia. J Int AIDS Soc, 2015, 18(1): 19317. doi:10.7448/IAS.18.1.19317.
[13]	Verrall AJ, Netea MG, Alisjahbana B, et al. Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology, 2014, 141(4): 506-513. doi:10.1111/imm.12223. pmid: 24754048
[14]	Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis, 2009, 48(1): 72-82. doi:10.1086/594126. pmid: 19046064
[15]	Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health, 2006, 120(1): 33-41. doi:10.1016/j.puhe.2005.03.017. pmid: 16129465
[16]	Suthar AB, Lawn SD, del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med, 2012, 9(7): e1001270. doi:10.1371/journal.pmed.1001270.
[17]	中国性病艾滋病防治协会HIV合并结核病专业委员会. 人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识. 中华传染病杂志, 2022, 40(1): 6-19. doi:10.3760/cma.j.cn311365-20211105-00387.
[18]	Sun J, Liu L, Shen J, et al. Trends in baseline CD 4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study. BMC Infect Dis, 2017, 17(1): 285. doi:10.1186/s12879-017-2398-5.
[19]	Liu L, Zhang R, Tang Y, et al. The importance of non-tuberculous mycobacteria identification in Chinese patients infected with HIV. Biosci Trends, 2018, 12(5): 515-516. doi:10.5582/bst.2018.01254.
[20]	Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet, 2010, 376(9738): 355-366. doi:10.1016/S0140-6736(10)60832-X. pmid: 20650513
[21]	Tellez-Navarrete NA, Ramon-Luing LA, Muñoz-Torrico M, et al. Malnutrition and tuberculosis: the gap between basic research and clinical trials. J Infect Dev Ctries, 2021, 15(3): 310-319. doi:10.3855/jidc.12821.
[22]	Li A, Yuan SY, Li QG, et al. Prevalence and risk factors of malnutrition in patients with pulmonary tuberculosis: a systematic review and meta-analysis. Front Med (Lausanne), 2023, 10: 1173619. doi:10.3389/fmed.2023.1173619.
[23]	Feleke BE, Feleke TE, Biadglegne F. Nutritional status of tuberculosis patients, a comparative cross-sectional study. BMC Pulm Med, 2019, 19(1): 182. doi:10.1186/s12890-019-0953-0. pmid: 31638950
[24]	Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med, 1979, 139(3): 337-339. pmid: 426578
[25]	Alpert PL, Munsiff SS, Gourevitch MN, et al. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis, 1997, 24(4): 661-668. doi:10.1093/clind/24.4.661. pmid: 9145741
[26]	郭新枝, 陈裕. 吸毒对肺结核患者病情的影响. 医药论坛杂志, 2003, 24(20): 11-12. doi:10.3969/j.issn.1672-3422.2003.20.006.
[27]	谭毅刚, 陈小冰. 毒品依赖者患肺结核临床及预后分析. 实用医学杂志, 2001, 17(7): 624. doi:10.3969/j.issn.1006-5725.2001.07.028.
[28]	Rusen ID, Yuan L, Millson ME. Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto. CMAJ, 1999, 160(6): 799-802.
[29]	中华医学会感染病学分会艾滋病学组, 中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识. 中华临床感染病杂志, 2017, 10(2): 81-90. doi:10.3760/cma.j.issn.1674-2397.2017.02.001.
[30]	Soeters HM, Napravnik S, Patel MR, et al. The effect of tuberculosis treatment on virologic and CD4⁺ cell count response to combination antiretroviral therapy: a systematic review. AIDS, 2014, 28(2): 245-255. doi:10.1097/01.aids.0000434936.57880.cd. pmid: 24072197
[31]	孙建军, 卢洪洲. 艾滋病合并结核病的诊治近况. 国际流行病学传染病学杂志, 2020, 47(2): 73-76. doi:10.3760/cma.j.cn331340-20200301-00041.
[32]	Ren Z, Zhao F, Chen H, et al. Nutritional intakes and associated factors among tuberculosis patients: a cross-sectional study in China. BMC Infect Dis, 2019, 19(1): 907. doi:10.1186/s12879-019-4481-6. pmid: 31664922
[33]	Chen W, Ding Q, Zhang SK, et al. Nutritional status in patients with active pulmonary tuberculosis and new nutritional risk screening model for active tuberculosis: a national, multicenter, cross-sectional study in China. J Thorac Dis, 2023, 15(5): 2779-2799. doi:10.21037/jtd-23-623. pmid: 37324100
[34]	Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis, 2016, 63(7): e147-e195. doi:10.1093/cid/ciw376.
[35]	秦璐. 反馈式健康教育结合强化心理护理对肺结核吸毒患者心理状态及应对方式的影响. 中国现代药物应用, 2019, 13(7):185-187. doi:10.14164/j.cnki.cn11-5581/r.2019.07.106.
[36]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1): 12-22. doi:10.3969/j.issn.1000-6621.2021.01.004.